HIKMA Pharmaceuticals PLC
HIK | IL
Overview
Corporate Details
- ISIN(s):
- GB00B0LCW083
- LEI:
- 549300BNS685UXH4JI75
- Country:
- United Kingdom
- Address:
- 1 New Burlington Place, W1S 2HR London
- Website:
- https://www.hikma.com/home/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures, and markets a broad range of pharmaceutical products. The company's operations are structured across three primary business segments: Injectables, Branded, and Generics. Its portfolio includes branded generics, non-branded generics, specialty products, and in-licensed medicines. For over 45 years, Hikma has focused on its mission to make high-quality medicines accessible and affordable. It serves retail and hospital customers across its key markets in North America, the Middle East & North Africa (MENA), and Europe, leveraging a strong local manufacturing and distribution presence.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for HIKMA Pharmaceuticals PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-22 13:02 |
Director's Dealing
Director/PDMR Shareholding
|
English | 14.5 KB | |
| 2025-08-13 14:51 |
Director's Dealing
Director/PDMR Shareholding
|
English | 17.9 KB | |
| 2025-08-08 13:59 |
Director's Dealing
Director/PDMR Shareholding
|
English | 14.6 KB | |
| 2025-08-07 08:00 |
Earnings Release
Half-year Report
|
English | 884.0 KB | |
| 2025-07-09 10:00 |
Report Publication Announcement
Notice of Results
|
English | 12.9 KB | |
| 2025-07-07 10:16 |
Report Publication Announcement
Publication of Offering Circular
|
English | 8.0 KB | |
| 2025-06-05 15:05 |
Director's Dealing
Director/PDMR Shareholding
|
English | 14.4 KB | |
| 2025-06-03 14:02 |
Director's Dealing
Director/PDMR Shareholding
|
English | 89.1 KB | |
| 2025-05-29 08:00 |
Capital/Financing Update
Fitch upgrades Hikma to ‘BBB’
|
English | 11.3 KB | |
| 2025-05-15 13:00 |
Earnings Release
Medium-term Group guidance ahead of US site visit
|
English | 12.5 KB | |
| 2025-05-08 11:48 |
Regulatory News Service
S&P upgrades Hikma to ‘BBB’
|
English | 11.3 KB | |
| 2025-05-08 09:21 |
Legal Proceedings Report
Settlement agreement for Xyrem® US lawsuits
|
English | 15.2 KB | |
| 2025-04-30 14:21 |
Director's Dealing
Director/PDMR Shareholding
|
English | 27.3 KB | |
| 2025-04-24 18:16 |
Post-Annual General Meeting Information
Special Business passed at AGM
|
English | 329.0 KB | |
| 2025-04-24 16:55 |
Post-Annual General Meeting Information
Result of AGM
|
English | 48.9 KB |
Automate Your Workflow. Get a real-time feed of all HIKMA Pharmaceuticals PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for HIKMA Pharmaceuticals PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
